Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AIM Immunotech, Amerimmune, Ampio, Astrazeneca, Bioage Labs, Biophytis, Curevac, Edesa, Eisai, Glaxosmithkline, Harbour Biomed, Histogen, Immutep, Incyte, Medicago, Merck, Moderna, Neurorx, Noxopharm, Reithera, Sanford Burnham Prebys Medical Discovery Institute, University of Hong Kong.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Alar, Algernon, Apeiron, Ascletis, Atossa, Atyr, Beigene, Bioaegis, Bioarctic, Biontech, Boehringer Ingelheim, Canbridge, Chromis, Edesa, Eisai, Eli Lilly, Evgen, Formosa, Gannex, Genentech, Gilead, Glaxosmithkline, Harbour Biomed, Immunitybio, Impact, Kintor, Moderna, Molecular Partners, Novartis, Novavax, Opthea, Pfizer, Quantum Leap, Rigel, Sagimet, Sanofi, Sosei, Takeda, Translate, VBI Vaccines, Vir, Viriom.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Aerpio, Aim, Alteogen, Apellis, Apollomics, Atea, Bharat, Brii, Can-Fite, Cerecor, Cytodyn, Glaxosmithkline, Immunitybio, Immutep, Innovation, Longeveron, Merck, Morphosys, Nantkwest, Ocugen, Ridgeback, Roche, Vir.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aivita Biomedical, Altimmune, Ampio, Aslan, Biontech, Chimerix, Constant, Glaxosmithkline, Gtreebnt, I-Mab, Innovation, Innovent Biologics, LG Chem Life Sciences, Neurorx, Novavax, Opthea, Partner, Pfizer, Redhill, Regeneron, Regentree, Revive, Samsung Bioepis, Stero, Takeda, Takis, Theravance, Union.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Adagio, Algernon, Astellas, Bionomics, Biontech, Biophytis, Clene, Diffusion, Evgen, Gannex, Glaxosmithkline, Immunic, India Globalization Capital, Kintor, Kyowa Kirin, Mesoblast, Neuren, Novavax, Pfizer, PTC, Realta Life Sciences, Recce, Redhill, Sagent, Sanofi, Vtv.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Neurorx, Takeda, Tessa, Turn, University of Oxford.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Agenus, Astrazeneca, Atea, Bioarctic, Biophytis, Botanix, Corvus, Covaxx, Daiichi Sankyo, Dong-A, Dynavax Technologies, Eiger, Eisai, Enlivex, Eucure, Glaxosmithkline, Golden, I-Mab, Innocare, Junshi, Neurorx, Reistone, Sanofi, Sinovac, Vaxart, Veru.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Appili, Astrazeneca, Beigene, Daiichi Sankyo, Dimerix, Dr. Reddy’s, Dynavax, Eli Lilly, Eucure Beijing, Glaxosmithkline, Humanigen, I-Mab, Immutep, Innovation, Johnson & Johnson, Lead Discovery Center, Morphosys, Novavax, Oncosec Medical, Qurient, Redhill, Regeneron, Sichuan Clover, Sorrento, Takeda, Valneva, VBL, Vicore, Vir.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abcellera, Algernon, Aribio, Aslan, Biophytis, Bio-Thera Solutions, Brickell, Cardiol, Debiopharm, Dynavax, Eli Lilly, Grifols, Immutep, Jemincare, Kaken, Medigen Vaccine, Moderna, Senhwa, Sinomab, Synairgen, Zydus Cadila.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Alexion, Ampio, Atyr, Caladrius, Celltrion, Cyxone, Gannex, Glaxosmithkline, Glow Lifetech, Helsinn Healthcare, Kyorin, MGC, Relay Medical, Rockwell Medical, Senhwa, Shanghai Fosun, Sorrento, Swiss, Synairgen, Taiho, Verona, Vir.